Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells Corrigendum in /10.3892/or.2023.8586

Zhang,Wenqing; Zhou,Kaili; Zhang,Xue; Wu,Chenglong; Deng,Dan; Yao,Zhirong

doi:10.3892/or.2021.7990

Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells

Corrigendum in: /10.3892/or.2023.8586

Authors:
- Wenqing Zhang
- Kaili Zhou
- Xue Zhang
- Chenglong Wu
- Dan Deng
- Zhirong Yao
View Affiliations

Affiliations: Department of Dermatology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200092, P.R. China
Published online on: February 22, 2021 https://doi.org/10.3892/or.2021.7990
Article Number: 39
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The long non‑coding RNA (lncRNA) H19 and microRNA(miR)‑675 were reported to serve an important role in the tumorigenesis and metastasis of numerous cancer types by promoting the epithelial‑mesenchymal transition (EMT) process; however, the underlying mechanisms of action of H19 and miR‑675 in cutaneous squamous cell carcinoma (cSCC) remain unknown. The mRNA expression levels of H19 and miR‑675 were analyzed using reverse transcription‑quantitative PCR, and Cell Counting Kit‑8, wound healing and Transwell assays were performed to analyze the cell proliferation, migration and invasion of cSCC cells, respectively. The levels of cell apoptosis were also determined using a TUNEL assay. Protein expression levels of p53 and marker proteins related to the EMT process were analyzed using western blotting. In addition, a dual luciferase reporter assay was performed to determine the interactions between H19, miR‑675 and p53. The results of the present study revealed that the expression levels of H19 and miR‑675 were upregulated in cSCC tissues and cSCC cell lines. The knockdown of H19 or miR‑675 expression inhibited cell proliferation, migration and invasion, but induced cell apoptosis. In addition, the expression levels of EMT‑related markers were also downregulated. The overexpression of H19 upregulated the expression levels of its predicted target, miR‑675, which subsequently promoted the EMT process and downregulated the expression levels of p53. Conversely, the genetic silencing of H19 or miR‑675 inhibited proliferation and invasion in SCL1 and A431 cSCC cell lines. In conclusion, the findings of the present study provided novel insight into the potential role of H19 and miR‑675 in the development, metastasis and progression of cSCC, which may help the development of treatments for cSCC.

View Figures

View References

1	Motaparthi K, Kapil JP and Velazquez EF: Cutaneous squamous cell carcinoma: Review of the eighth edition of the American Joint Committee on Cancer staging guidelines, prognostic factors, and histopathologic variants. Adv Anat Pathol. 24:171–194. 2017. View Article : Google Scholar : PubMed/NCBI
2	Ackerman AB and Mones JM: Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol. 155:9–22. 2006. View Article : Google Scholar : PubMed/NCBI
3	Koike Y, Yozaki M, Kuwatsuka Y and Utani A: Epithelial-mesenchymal transition in Bowen's disease when arising de novo and acquiring invasive capacity. J Dermatol. 45:748–750. 2018. View Article : Google Scholar : PubMed/NCBI
4	Ishitsuka Y, Kawachi Y, Taguchi S, Maruyama H, Nakamura Y, Fujisawa Y, Furuta J, Nakamura Y, Ishii Y and Otsuka F: Pituitary tumor-transforming gene 1 as a proliferation marker lacking prognostic value in cutaneous squamous cell carcinoma. Exp Dermatol. 22:318–322. 2013. View Article : Google Scholar : PubMed/NCBI
5	Graindorge S, Cognat V, Johann To Berens P, Mutterer J and Molinier J: Photodamage repair pathways contribute to the accurate maintenance of the DNA methylome landscape upon UV exposure. PLoS Genet. 15:e10084762019. View Article : Google Scholar : PubMed/NCBI
6	Fernandez Figueras MT: From actinic keratosis to squamous cell carcinoma: Pathophysiology revisited. J Eur Acad Dermatol Venereol. 31 (Suppl 2):S5–S7. 2017. View Article : Google Scholar
7	Lobl M, Grinnell M, Phillips A, Abels J and Wysong A: The correlation between immunohistochemistry findings and metastasis in squamous cell carcinoma: A review. Dermatol Surg. Nov 3–2020.(Epub ahead of print). doi: 10.1097/DSS.0000000000002850. View Article : Google Scholar : PubMed/NCBI
8	Tian K, Liu W, Zhang J, Fan X, Liu J, Zhao N, Yao C and Miao G: MicroRNA-125b exerts antitumor functions in cutaneous squamous cell carcinoma by targeting the STAT3 pathway. Cell Mol Biol Lett. 25:122020. View Article : Google Scholar : PubMed/NCBI
9	Cerk S, Schwarzenbacher D, Adiprasito JB, Stotz M, Hutterer GC, Gerger A, Ling H, Calin GA and Pichler M: Current status of long non-coding RNAs in human breast cancer. Int J Mol Sci. 17:14852016. View Article : Google Scholar
10	Hao S, Yao L, Huang J, He H, Yang F, Di Y, Jin C and Fu D: Genome-wide analysis identified a number of dysregulated long noncoding RNA (lncRNA) in human pancreatic ductal adenocarcinoma. Technol Cancer Res Treat. 17:15330346177484292018. View Article : Google Scholar : PubMed/NCBI
11	Ponzio G, Rezzonico R, Bourget I, Allan R, Nottet N, Popa A, Magnone V, Rios G, Mari B and Barbry P: A new long noncoding RNA (lncRNA) is induced in cutaneous squamous cell carcinoma and down-regulates several anticancer and cell differentiation genes in mouse. J Biol Chem. 292:12483–12495. 2017. View Article : Google Scholar : PubMed/NCBI
12	Pachnis V, Belayew A and Tilghman SM: Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes. Proc Natl Acad Sci USA. 81:5523–5527. 1984. View Article : Google Scholar : PubMed/NCBI
13	Zhou W, Ye XL, Xu J, Cao MG, Fang ZY, Li LY, Guan GH, Liu Q, Qian YH and Xie D: The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b. Sci Signal. 10:eaak95572017. View Article : Google Scholar : PubMed/NCBI
14	Wu J, Qin Y, Li B, He WZ and Sun ZL: Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma. Genomics. 91:443–450. 2008. View Article : Google Scholar : PubMed/NCBI
15	Li X, Li Q, Jin X, Guo H and Li Y: Long non-coding RNA H19 knockdown inhibits the cell viability and promotes apoptosis of thyroid cancer cells through regulating the PI3K/AKT pathway. Exp Ther Med. 18:1863–1869. 2019.PubMed/NCBI
16	Ghafouri-Fard S, Esmaeili M and Taheri M: H19 lncRNA: Roles in tumorigenesis. Biomed Pharmacother. 123:1097742020. View Article : Google Scholar : PubMed/NCBI
17	Wang WT, Ye H, Wei PP, Han BW, He B, Chen ZH and Chen YQ: LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner. J Hematol Oncol. 9:1172016. View Article : Google Scholar : PubMed/NCBI
18	Yang Q, Wang X, Tang C, Chen X and He J: H19 promotes the migration and invasion of colon cancer by sponging miR-138 to upregulate the expression of HMGA1. Int J Oncol. 50:1801–1809. 2017. View Article : Google Scholar : PubMed/NCBI
19	Shi G, Li H, Gao F and Tan Q: lncRNA H19 predicts poor prognosis in patients with melanoma and regulates cell growth, invasion, migration and epithelial-mesenchymal transition in melanoma cells. Onco Targets Ther. 11:3583–3595. 2018. View Article : Google Scholar : PubMed/NCBI
20	Cai X and Cullen BR: The imprinted H19 noncoding RNA is a primary microRNA precursor. RNA. 13:313–316. 2007. View Article : Google Scholar : PubMed/NCBI
21	Simons M and Raposo G: Exosomes-vesicular carriers for intercellular communication. Curr Opin Cell Biol. 21:575–581. 2009. View Article : Google Scholar : PubMed/NCBI
22	Kim NH, Lee CH and Lee AY: H19 RNA downregulation stimulated melanogenesis in melasma. Pigment Cell Melanoma Res. 23:84–92. 2010. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
24	Betel D, Wilson M, Gabow A, Marks DS and Sander C: The microRNA.org resource: Targets and expression. Nucleic Acids Res. 36((Database Issue)): D149–D153. 2008.PubMed/NCBI
25	Miyashita T and Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:293–299. 1995. View Article : Google Scholar : PubMed/NCBI
26	Sand M, Bechara FG, Gambichler T, Sand D, Bromba M, Hahn SA, Stockfleth E and Hessam S: Circular RNA expression in cutaneous squamous cell carcinoma. J Dermatol Sci. 83:210–218. 2016. View Article : Google Scholar : PubMed/NCBI
27	Wang Y, Sun B, Wen X, Hao D, Du D, He G and Jiang X: The roles of lncRNA in cutaneous squamous cell carcinoma. Front Oncol. 10:1582020. View Article : Google Scholar : PubMed/NCBI
28	Li J, Su T, Zou C, Luo W, Shi G, Chen L, Fang C and Li C: Long non-coding RNA H19 regulates porcine satellite cell differentiation through miR-140-5p/SOX4 and DBN1. Front Cell Dev Biol. 8:5187242020. View Article : Google Scholar : PubMed/NCBI
29	Lecerf C, Peperstraete E, Le Bourhis X and Adriaenssens E: Propagation and maintenance of cancer stem cells: A major influence of the long non-coding RNA H19. Cells. 9:26132020. View Article : Google Scholar
30	Hua Q, Lv X, Gu X, Chen Y, Chu H, Du M, Gong W, Wang M and Zhang Z: Genetic variants in lncRNA H19 are associated with the risk of bladder cancer in a Chinese population. Mutagenesis. 31:531–538. 2016. View Article : Google Scholar : PubMed/NCBI
31	Liu G, Xiang T, Wu QF and Wang WX: Long noncoding RNA H19-derived miR-675 enhances proliferation and invasion via RUNX1 in gastric cancer cells. Oncol Res. 23:99–107. 2016. View Article : Google Scholar : PubMed/NCBI
32	Peperstraete E, Lecerf C, Collette J, Vennin C, Raby L, Völkel P, Angrand PO, Winter M, Bertucci F, Finetti P, et al: Enhancement of breast cancer cell aggressiveness by lncRNA H19 and its Mir-675 derivative: Insight into shared and different actions. Cancers (Basel). 12:17302020. View Article : Google Scholar
33	Hu Q, Yin J, Zeng A, Jin X, Zhang Z, Yan W and You Y: H19 functions as a competing endogenous RNA to regulate EMT by sponging miR-130a-3p in glioma. Cell Physiol Biochem. 50:233–245. 2018. View Article : Google Scholar : PubMed/NCBI
34	Yang S, Fang F, Yu X, Yang C, Zhang X, Wang L, Zhu L, Shao K and Zhu T: Knockdown of H19 inhibits the pathogenesis of acne vulgaris by targeting the miR-196a/TLR2/NF-κB axis. Inflammation. 43:1936–1947. 2020. View Article : Google Scholar : PubMed/NCBI
35	Iempridee T: Long non-coding RNA H19 enhances cell proliferation and anchorage-independent growth of cervical cancer cell lines. Exp Biol Med (Maywood). 242:184–193. 2017. View Article : Google Scholar : PubMed/NCBI
36	Zheng ZH, Wu DM, Fan SH, Zhang ZF, Chen GQ and Lu J: Upregulation of miR-675-5p induced by lncRNA H19 was associated with tumor progression and development by targeting tumor suppressor p53 in non-small cell lung cancer. J Cell Biochem. 120:18724–18735. 2019. View Article : Google Scholar : PubMed/NCBI
37	Tay Y, Rinn J and Pandolfi PP: The multilayered complexity of ceRNA crosstalk and competition. Nature. 505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
38	García-Sancha N, Corchado-Cobos R, Pérez-Losada J and Cañueto J: MicroRNA dysregulation in cutaneous squamous cell carcinoma. Int J Mol Sci. 20:21812019. View Article : Google Scholar
39	Singh A and Settleman J: EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
40	Lee JM, Dedhar S, Kalluri R and Thompson EW: The epithelial-mesenchymal transition: New insights in signaling, development, and disease. J Cell Biol. 172:973–981. 2006. View Article : Google Scholar : PubMed/NCBI
41	Gumbiner BM: Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol. 6:622–634. 2005. View Article : Google Scholar : PubMed/NCBI
42	Ivaska J, Vuoriluoto K, Huovinen T, Izawa I, Inagaki M and Parker PJ: PKCepsilon-mediated phosphorylation of vimentin controls integrin recycling and motility. EMBO J. 24:3834–3845. 2005. View Article : Google Scholar : PubMed/NCBI
43	Wang L and Yu P: miR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53. Oncol Rep. 36:3225–3232. 2016. View Article : Google Scholar : PubMed/NCBI